DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...

Previously, the treatment had only been available as a lyophilized powder for reconstitution that required administration by a healthcare professional. The Food and Drug Administration has approved ...

Fosnetupitant, palonosetron; 235mg/0.25mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free. Store Akynzeo capsules at 20 °C to 25 °C (68 °F to 77 °F); ...

First-and-only FDA-approved solution formulation of this medication now available in 100 mcg per 5 mL, 200 mcg per 5 mL and 500 mcg per 5 mL single-dose vials LAKE ZURICH, Ill.--(BUSINESS ...